2.1
Digital therapy for chronic tic disorders and Tourette syndrome could allow people to have treatment for these conditions remotely.
Closed for comments This consultation ended on at Request commenting lead permission
Digital therapy for chronic tic disorders and Tourette syndrome could allow people to have treatment for these conditions remotely.
NICE has assessed 2 digital technologies for chronic tic disorders and Tourette syndrome. The technologies have different features but both provide therapeutic intervention. The criteria for including technologies in this assessment are in the final scope on the NICE website. The included technologies are:
Online Remote Behavioural Intervention for Tics (ORBIT; Mindtech): this is an online guided self-help intervention that delivers an evidence-based behaviour therapy for chronic tic disorders and Tourette syndrome. It is for children and young people 9 to 17 years and was developed from an existing research platform (BIP TIC) in Sweden. It was designed to be age-appropriate in appearance for use by children and young people 9 to 17 years and their parents or carers. It includes videos, animations and interactive scripts. ORBIT provides a form of behavioural therapy called an exposure with response-prevention intervention. It is supported by an online therapist across a 10-week programme. The programme is delivered alongside psychoeducation, parental support, reward and functional analyses through a secure internet platform. It includes self-help guided chapters that include tic psychoeducation. These are followed by exposure and response-prevention behavioural therapy tasks. It also includes separate chapters for parents and carers to further support them in their roles. The therapist has 10 to 20 minutes of contact with the family each week, during which they promote engagement with the intervention and answer questions rather than delivering therapeutic content. The programme teaches children and young people to suppress their tics while tolerating the urges to tic. ORBIT has been studied as part of NIHR-funded UK-based trials. ORBIT does not require CE marking because it is not considered a medical device.
Neupulse (Neurotherapeutics): this is a wearable wrist-worn neuromodulation device with a corresponding phone app. It is for treating chronic tic disorders and Tourette syndrome in children and young people 12 and over and in adults. The device addresses the imbalances in neural activity that are associated with tics and premonitory urges by modulating neural oscillations within the brain's sensorimotor networks. It delivers low-intensity electrical pulses to the median nerve (median nerve stimulation) to reduce tic frequency and severity. Neupulse produces low-intensity electrical stimulation up to a maximum of 14 mA. The device is currently under development for over-the-counter sale and will be supported by written and video-based guidance and a technical support helpline. Neupulse is working towards CE and UKCA marking, and it is estimated that it will be available in 2026.
See table 1 in the external assessment group's assessment report for details of the technologies.
The scope for this early value assessment included a targeted population of people with a diagnosed primary tic disorder who have had psychoeducation, but their tics continue to be bothersome. There is no comprehensive clinical guideline for the diagnosis and management of tic disorders in children and young people in the UK. NICE's guideline on suspected neurological conditions: recognition and referral contains some information on tic disorders. It recommends that children and young people with tic disorders that have a significant impact on their quality of life, should be considered for referral to specialist mental health services, neurodevelopmental teams or for neurological assessment. Adults with tic disorders should be considered for neurological assessment if their symptoms are severe and the disorder continues to cause distress.
In the UK, people with chronic tic disorders and Tourette syndrome attend an initial appointment with a GP in primary care. When a tic disorder has a significant impact on a person's quality of life, they are usually referred to appropriate secondary or tertiary care services (depending on the presentation, comorbidities, and local specialist clinics). Children and young people may be referred to mental health services (including to the Children and Young People's Mental Health Services), neurodevelopmental teams, paediatric teams or paediatric neurology teams, depending on local services and pathways. Adults are usually referred to neurology services or to neuropsychiatry clinics. Because tics may improve with time, NICE's guideline on suspected neurological conditions: recognition and referral recommends a watch-and-wait approach for people presenting in primary care, especially if they do not have functional impairment. Current practice varies by location across the UK and by the availability of local services but, in general, treatment options for chronic tic disorders include:
psychoeducation
behavioural therapy
pharmacological therapy
deep brain stimulation and
Botox.
Accepted evidence-based treatment options for diagnosed tic disorders are psychoeducation as a first line option and behavioural therapies for people who still have difficulties with their tics. For some people, behavioural approaches may not be as effective, feasible or accessible and other possible treatments (with or without behavioural therapies) will be discussed. Digital therapy for chronic tic disorders and Tourette syndrome would be offered after clinical assessment and diagnosis. These interventions should only be considered if the person (and parent or carer where appropriate) has had access to a form of psychoeducation. If the tic disorder continues to cause difficulties, a healthcare professional may consider referring people for these interventions.
The comparator is standard care for managing chronic tic disorders and Tourette syndrome, including psychoeducation and behavioural therapy. Standard care varies significantly across clinical practice. Digital therapy would be used in addition to standard care.
There was no evidence comparing any of the interventions with current standard care. The online psychoeducation may be a more active comparator than face-to-face psychoeducation in current UK clinical practice. In the economic modelling, the comparator for ORBIT is online psychoeducation in children and young people. The comparator for Neupulse is a waitlist control (that is, no stimulation) in children and young people 12 years and over, and in adults.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation